Recent News

Sep 22, 2017

News Scan for Sep 22, 2017

Vaccine-related polio
More chikungunya in France, Italy
Waning flu vaccine protection
H5N8 in South Africa
Sep 07, 2017

News Scan for Sep 07, 2017

Saudi MERS case
Zika retina damage
VHF PPE profile
Yellow fever in Brazil
Pakistani polio case
Sep 01, 2017

News Scan for Sep 01, 2017

Saudi MERS infection
New polio cases
ESBL E coli in Germany
Aug 21, 2017

News Scan for Aug 21, 2017

Backyard poultry and Salmonella
New polio cases
Cholera in Yemen rebel areas
Aug 15, 2017

News Scan for Aug 15, 2017

Saudi MERS case
H7N9 in China
Recurrent C diff treatment
Oropouche fever in Brazil
Hendra virus threat
Plant-based polio vaccine
Aug 14, 2017

News Scan for Aug 14, 2017

MERS case
Multidrug-resistant BSIs in India
Polio emergency continues
Ricin vaccine funding
Chikungunya in the Americas
Aug 11, 2017

News Scan for Aug 11, 2017

MERS cases in Saudi Arabia
More papaya Salmonella
H3N2v cases in Ohio
Vaccine-derived polio
Jul 24, 2017

News Scan for Jul 24, 2017

Zika pregnancy testing updated
Ebola detection in semen
H5N8 outbreaks
Polio in Afghanistan
Jul 19, 2017

News Scan for Jul 19, 2017

Lab-linked Salmonella
Ebola persistence
Polio in Syria
Sri Lanka dengue battle
Measles and travel
Acute flaccid myelitis
Jul 17, 2017
infant vaccination

WHO: 1 in 10 infants received no vaccinations last year

Babies living in countries affected by conflict made up more than half of the total of unvaccinated group.

Resources & Literature

Recent Literature

Bahl S, Hampton LM, Bhatnagar P, et al. Detection of Sabin-like type 2 poliovirus from sewage after global cessation of trivalent oral poliovirus vaccine — Hyderabad and Ahmedabad, India, August-September 2016. (Notes from the field) MMWR 2017 Jan 6;65(52):1493-4

Benn CS, Jacobsen LH, Fisker AB, et al. Campaigns with oral polio vaccine may lower mortality and create unexpected results. Vaccine 2017 (published online Jan 27)

Berchenko Y, Manor Y, Freedman LS, et al. Estimation of polio infection prevalence from environmental surveillance data. Sci Transl Med 2017 Mar 29;9(383):eaaf6786

Collett MS, Hincks JR, Benschop K, et al. Antiviral activity of pocapavir in a randomized, blinded, placebo-controlled human oral poliovirus vaccine challenge model. J Infect Dis 2016 (published online Dec 8)

Diop OM, Asghar H, Gavrilin E, et al. Virologic monitoring of poliovirus type 2 after oral poliovirus vaccine type 2 withdrawal in April 2016 — worldwide, 2016-2017. MMWR 2017 May 26;66(20):538-42

Duizer E, Ruijs WL, van der Weijden CP, et al. Response to a wild poliovirus type 2 (WPV2)-shedding event following accidental exposure to WPV2, the Netherlands, April 2017. Euro Surveill 2017 May 25;22(21):pii=30542

Hsu CH, Mahamud A, Safdar RM, et al. Progress toward poliomyelitis eradication — Pakistan, January 2015-September 2016. MMWR 2016 Nov 25;65(46):1295-9

Hussain I, Mach O, Habib A, et al. Seroprevalence of anti-polio antibodies in children from polio high-risk areas of Pakistan: a cross-sectional survey 2015-2016. Pediatr Infect Dis J 2017 Sep;36(9):e230-6

John J, Giri S, Karthikeyan AS, et al. The duration of intestinal immunity after an inactivated poliovirus vaccine booster dose in children immunized with oral vaccine: a randomised controlled trial. J Infect Dis 2016 (published online Dec 21)

Liao G, Li R, Li C, et al. Phase III trial of a Sabin strain-based inactivated poliovirus vaccine. J Infect Dis 2016 (published online Sep 22)

Maes EF, Diop OM, Jorba J, et al. Surveillance systems to track progress toward polio eradication — worldwide, 2014-2016. MMWR Apr 7;66(13):359-65

Marin M, Patel M, Oberste S, et al. Guidance for assessment of poliovirus vaccination status and vaccination of children who have received poliovirus vaccine outside the United States. MMWR 2017 Jan 13;66(01):23-5

Martinez M, Shukla H, Nikulin J, et al. Progress toward poliomyelitis eradication — Afghanistan, January 2016-June 2017. MMWR 2017 Aug 18;66(32):854-8

Mbaeyi C, Ryan MJ, Smith P, et al. Response to a large polio outbreak in a setting of conflict Middle East, 2013-2015. MMWR 2017 Mar 3;66(8):227-31

Mbaeyi C, Shukla H, Smith P, et al. Progress toward poliomyelitis eradication — Afghanistan, January 2015-August 2016. MMWR 2016 Nov 4;65(43):1195-9

Mohanty MC, Madkaikar MR, Desai M, et al. Poliovirus excretion in children with primary immunodeficiency disorders, India. Emerg Infect Dis 2017 (published online Aug 28)

Nnadi C, Damisa E, Esapa L, et al. Continued endemic wild poliovirus transmission in security-compromised areas — Nigeria, 2016. MMWR 2017 Feb 24;66(7):190-3

Pons-Salort M, Molodecky NA, O'Reilly KM, et al. Population immunity against serotype-2 poliomyelitis leading up to the global withdrawal of the oral poliovirus vaccine: spatio-temporal modelling of surveillance data. PLoS Med 2016 Oct 4;13(10):e1002140

Previsani N, Singh H, St. Pierre J, et al. Progress toward containment of poliovirus type 2 worldwide, 2017. MMWR 2017 Jun 23;66(24):649-52

Rivera L, Pedersen RS, Pena L, et al. Immunogenicity and safety of three aluminum hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority, observer-blinded, randomised, and controlled dose investigation trial. Lancet Infect Dis 2017 (published online Apr 25)

Shirreff G, Wadood MZ, Vaz RG, et al. Estimated effect of inactivated poliovirus vaccine campaigns, Nigeria and Pakistan, January 2014-April 2016. Emerg Infect Dis 2016 (published online Nov 18)

Tanluchi M, Famulare M, Zaman K, et al. Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study. Lancet Infect Dis 2017 (published online Jul 7)

Weil M, Shulman LM, Heiman S, et al. Prolonged excretion of type-2 poliovirus from a primary immune deficient patient during the transition to a type-2 poliovirus-free world, Israel, 2016. Euro Surveill 2016 Nov 24;21(47):pii=30408

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»


Unrestricted financial support provided by

Bentson Foundation 3MGilead Become an underwriter»